国家药品监督管理局药品审评中心数据显示，2026年2月4日，Biocon Pharma Limited的依维莫司片申请已获受理，受理号为JYHS2600002。

On Wednesday, Biocon stock slipped 0.55 per cent to settle at Rs 364.55 apiece on the BSE.

Biocon Ltd is quoting at Rs 373.85, up 0.42% on the day as on 12:44 IST on the NSE. The stock is down 4.2% in last one year as compared to a 8.62% gain in NIFTY and a 1.45% gain in the Nifty Pharma.

Biocon has completed the acquisition of the remaining equity shares of its unlisted subsidiary Biocon Biologics from Mylan Inc for $200 million, taking its total stake in Biocon Biologics to about 98% ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key markets as it races to be among the first few to reap a windfall after patents on ...

Shares of companies related to pharmaceuticals sector jumped on Sunday after Finance Minister Nirmala Sitharaman proposed Rs ...

Stocks to watch today: The stocks to watch today, 22 January 2026, include Eternal, InterGlobe Aviation, Eternal, Dr Reddy’s Laboratories, Biocon, Hindustan Petroleum Corporation Ltd (HPCL), CESC, ...

(RTTNews) - Biocon Biologics Ltd (BBL), a unit of Biocon Ltd (BIOCON), Thursday said that the U.S. Food and Drug Administration (FDA) has approved Jobevne, a biosimilar to Bevacizumab. Bevacizumab, ...

Budget 2024 proposes Rs 10,000 crore investment in biopharma. Anthem Biosciences, Biocon stocks jump. Impact on pharma sector ...

BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...